LinkedIn Logo

February 20-22, 2018

Boston, USA


Microtubular Proteins & Cytokines as Peripheral Biomarkers of Disease Progression in Neurodegenerative Disorders: a Novel Path Towards Innovative Pharmacological Interventions?

Alterations in microtubular proteins and cytokines in neurodegenerative disorders Tubulin post-translational modifications and TAU in plasma and CSF: from preclinical models to clinical settings Interaction between microtubular proteins and cytokines and possible pharmacological interventions

by aartid | January 9, 2017 | posted in | No Comments

Roundtable Discussions

Addressing the Clinical Trial Landscape Developing Novel Non Invasive Surrogate Biomarkers

by jessicae | November 9, 2016 | posted in | No Comments

by aartid | October 27, 2016 | posted in | No Comments

Chairman’s Closing Remarks

by aartid | | posted in | No Comments

Workshop Discussion with Audience

by aartid | | posted in | No Comments

Lunch & Networking

by aartid | | posted in | No Comments

Global Alzheimer’s Platform Foundation (GAP-NET) as a Public- Private Space for Coordinating Stakeholders Initiatives Against Alzheimer’s Disease in USA

by aartid | | posted in | No Comments

Foundational Regulatory Science Provides Actionable Solutions for Unmet Needs in Alzheimer Disease

• Examples highlighting the impact that could not have been achieved by one individual organization alone • Exploring CAMD development of global consensus clinical data standards for Alzheimer’s disease (CDISC) including: -Development of unified clinical trial database consisting of placebo data from multinational clinical trials -Regulatory qualification and endorsment for neuroimaging biomarkers for enrichment in… Read more

by aartid | | posted in | No Comments

The Accelerating Medicines Partnership-Alzheimer’s Disease (AMP-AD) as a Public-Private Space for Pre-clinical Validation in Drug Discovery in USA

by aartid | | posted in | No Comments

Public-Private Partnerships Through the Innovative Medicines Initiative (IMI)

by aartid | | posted in | No Comments